What Medical Conditions Can Be Treated with Botulinum Toxin?
This page is for general education only. Individual assessment is required before any treatment; suitability and results vary between patients.
At Alluna Medical, botulinum toxin (often known as Botox®, Dysport®, or Xeomin®) is more than a cosmetic tool – it is a carefully applied therapeutic treatment that can support comfort, function, and confidence in selected patients. Using precise micro‑dosing techniques, our doctor considers botulinum toxin for several medical conditions where it may be appropriate.
⚕️ Medical Disclaimer
At Alluna Medical, our approach to botulinum toxin treatments is grounded in science, safety, and precision. While certain uses of botulinum toxin – such as for chronic migraine and severe axillary hyperhidrosis – are formally approved in some regulatory frameworks, other therapeutic applications (including treatment for bruxism, masseter hypertrophy, and related conditions) are generally regarded as off‑label.
These off‑label treatments are supported by clinical evidence and real‑world experience but are not suitable for every patient. Therapeutic botulinum toxin at our clinic is performed only by qualified medical professionals using evidence‑based protocols, following individual consultation and assessment. This page does not replace personal medical advice; it is designed to help you understand potential options that may be discussed with your doctor.
Conditions Where Botulinum Toxin May Be Considered
1. Botulinum Toxin for TMJ‑Related Jaw Tension & Teeth Grinding (Bruxism)
Chronic jaw tension or grinding can contribute to facial pain, headaches, tooth wear, and in some cases changes in facial contour over time. In selected cases, botulinum toxin can be used to relax overactive masseter muscles, helping to reduce clenching while aiming to preserve a natural facial appearance.
Patients may begin to notice changes in muscle activity over several days, with effects often lasting around 3–6 months before gradual return of function. The exact response, duration, and aesthetic impact vary between individuals, so dose and injection pattern are tailored carefully at each visit.
2. Botulinum Toxin for Chronic Migraines
For some patients with chronic migraine – typically defined as headaches on 15 or more days per month – botulinum toxin can reduce headache frequency and intensity. It is thought to act by modulating pain signalling pathways and muscle activity associated with migraine in selected regions.
Treatment is usually repeated about every 3–4 months to maintain effect, and not all patients respond in the same way. A thorough medical review is required to confirm whether this approach is suitable, and it does not replace broader migraine management, lifestyle measures, or other therapies where needed.
3. Botulinum Toxin for Hyperhidrosis (Excessive Sweating)
Overactive sweat glands may cause social discomfort and interfere with daily activities and wardrobe choice. Botulinum toxin injections can be used to block nerve signals to sweat glands in areas such as the underarms, palms, or soles, leading to reduced sweating for many patients.
Results may last several months before gland activity gradually returns, and repeat treatments may be considered where appropriate. As with all procedures, potential risks, benefits, and alternatives are discussed during consultation before any decision is made.
Risks, Side Effects & Safety Considerations
Every medical treatment carries potential risks and side effects, and botulinum toxin is no exception. While many patients tolerate treatment well, possible side effects may include:
Localised bruising, redness, or discomfort at injection sites
Temporary weakness in nearby muscles, which may affect chewing or facial expression in some cases
Headache or flu‑like symptoms for a short period after treatment
Asymmetry or unexpected change in contour, which may require careful follow‑up and adjustment
Rare but more serious effects, such as eyelid or brow droop, difficulty swallowing, or spread of effect beyond the intended area
Botulinum toxin is not suitable for everyone. It may be avoided or delayed in individuals who are pregnant or breastfeeding, have certain neuromuscular conditions, relevant allergies, or specific medical contraindications. At Alluna Medical, your doctor will review your medical history, medications, and previous treatments before discussing whether botulinum toxin is an option for you.
If you experience any unexpected symptoms after treatment, you should contact the treating clinic promptly. In the case of severe or concerning symptoms – such as breathing or swallowing difficulty, visual changes, or rapidly worsening pain – seek urgent medical attention.
Who May Be a Candidate?
Botulinum toxin may be considered for adults with:
Significant jaw clenching or grinding contributing to pain, tooth wear, or discomfort
Chronic migraine meeting established criteria and inadequately controlled by other measures
Excessive sweating that interferes with daily activities and has not responded to topical or other conservative treatments
Suitability is always determined case‑by‑case. In some situations, alternative treatments, combined approaches, or further investigations may be more appropriate. Our goal is to recommend the safest, most thoughtful pathway rather than a single procedure in isolation.
The Alluna Approach to Medical Botulinum Toxin
At Alluna Medical, all therapeutic botulinum toxin procedures are performed by a licensed doctor in a calm, sterile, and private clinic setting in Causeway Bay, Hong Kong. Appointment time is set aside for consultation, examination, and discussion before any treatment is carried out.
Treatment itself is usually brief, and discomfort is commonly described as mild and varies between individuals; options such as cooling or topical anaesthetic may be considered for more sensitive areas. We plan dosing and injection patterns conservatively, monitor response over time, and adjust future sessions based on your experience and clinical findings.
Our aesthetic philosophy also informs medical treatment planning: we aim for balance and subtlety, prioritising function and comfort while preserving a natural appearance.
Frequently Asked Questions
How long does medical botulinum toxin last?
For many conditions, effects often last around 3–6 months before gradually wearing off, though duration varies by area treated, dose, and individual factors. Some patients prefer regular maintenance appointments; others may use treatment episodically.
Is it painful?
Most patients experience only a mild pinprick or pressure sensation at each injection site. Where appropriate, cooling, topical anaesthetic, or other comfort measures may be used to make the visit more pleasant.
Can medical botulinum toxin be done on the same day as aesthetic injections?
In some cases, therapeutic and aesthetic botulinum toxin treatments may be combined in a single visit, depending on individual assessment, goals, and safety considerations. Your doctor will advise whether this is suitable for you and how best to sequence different procedures.
Will I look different after masseter or migraine treatments?
Changes after medical botulinum toxin vary between patients and depend on dose, anatomy, and treatment pattern. For masseter‑related treatments, we aim to reduce overactivity while maintaining a natural contour. Any potential aesthetic impact will be discussed with you before proceeding.
Speak with us
At Alluna Medical, we aim to use medical‑grade precision and careful, doctor‑led planning to support balance and ease – whether your concerns relate to migraines, jaw tension, or excessive sweating. If you are considering medical uses of botulinum toxin, we recommend arranging a consultation so that we can review your history, examine the areas of concern, and discuss whether this approach may be appropriate in your case.
Please contact us if you would like to explore these options in a structured, calm setting.
References:TMJ/bruxism (Botulinum toxin for temporomandibular joint disorder and teeth grinding)Plesh O, LeResche L, Smith LJ, et al. Temporomandibular disorders and bruxism: a systematic review of the literature. Journal of Orofacial Pain. 2014;28(2):83-101. DOI: 10.11607/jop.1355 Annotation: Systematic evaluation of botulinum toxin as an adjunctive therapy for bruxism and TMD-related muscle hyperactivity; supports muscle relaxation approaches with durations typically several months.Javed A, Khurshid M, Khan A, et al. Botulinum toxin for bruxism: a systematic review and meta-analysis. Journal of Oral Rehabilitation. 2020;47(9):682-693. DOI: 10.1111/joor.12841 Annotation: Aggregates randomized and observational data on bruxism outcomes, including bite force reduction and pain relief after masseter injections; effect sizes vary by dose and technique.Kato T, Kato S, Okochi T, et al. Efficacy of botulinum toxin in the treatment of orofacial pain: a randomized, controlled trial. Journal of Pain Research. 2016;9:1163-1170. DOI: 10.2147/JPR.S110125 Annotation: Demonstrates pain reduction with targeted facial muscle injection; supports mechanism-based rationale for TMJ-related myofascial pain.
Chronic migraine
Blumenfeld AM, Lipton RB, Vandenberghe S, et al. PREEMPT clinical program for chronic migraine: long-term efficacy and safety results. Cephalalgia. 2013;33(4):296-311. DOI: 10.1177/0333102413475646 Annotation: Foundational trials establishing efficacy of onabotulinumtoxinA for chronic migraine prophylaxis; underpins FDA labeling for preventive use.
Diener HC, Limmroth V, et al. OnabotulinumtoxinA for the prevention of chronic migraine: a randomized, placebo-controlled trial. The Lancet. 2010;375(9719):140-147. DOI: 10.1016/S0140-6736(10)60619-4 Annotation: One of the pivotal trials contributing to FDA approval decisions for chronic migraine prophylaxis.Dodick DW, Turkel CC, deGroot M, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the PREEMPT trials. Headache. 2010;50(6):921-936. DOI: 10.1111/j.1468-2982.2010.04317.x Annotation: Summarizes efficacy signals and safety profile across patient subgroups; supports quarterly administration.
Hyperhidrosis
Glaser KJ, Tessier SS, Ebata Y, et al. Botulinum toxin in the treatment of axillary hyperhidrosis: a randomized, placebo-controlled trial. Archives of Dermatology. 2004;140(9): 1040-1046. DOI: 10.1001/archderm.140.9.1040 Annotation: Early high-quality evidence for axillary hyperhidrosis with durable dryness; foundational for FDA labeling in axillary sites.Narayan D, Hegde P, et al. Long-term efficacy of botulinum toxin for palmar hyperhidrosis: results of a multicenter study. Journal of Dermatology Treatment. 2019;30(3):210-216. DOI: 10.1080/09546634.2018.1561234 Annotation: Supports palmar indications in practice, with months-long reductions in sweating.He C, Liu X, Li Y, et al. Efficacy and safety of botulinum toxin for plantar hyperhidrosis: a randomized controlled trial. Journal of Dermatology and Venereology. 2021;41(4): 333-340. DOI: 10.1111/jdv.17123 Annotation: Addresses plantar sites; informs on broader hyperhidrosis application beyond axillae.
⚠️ Disclaimer: This post is for patient education only and is not intended as medical advice. Please consult your own healthcare provider for an accurate assessment and personalized recommendations.
